Question 1

What specific benefits do you think NLY01 might provide for my MS?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis clinical trial (NCT07497399). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the study compare NLY01 to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis clinical trial (NCT07497399). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of NLY01?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis clinical trial (NCT07497399). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis clinical trial (NCT07497399). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of tests will I need to undergo while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis clinical trial (NCT07497399). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks related to the placebo treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis clinical trial (NCT07497399). Contact the study team or your healthcare provider for specific answers.

What this study is about